Cargando…
IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Pseudomonas aeruginosa airway infection increases risks of exacerbations and mortality in chronic obstructive pulmonary disease (COPD). We aimed to elucidate the role of IL-17 in the pathogenesis. We examined the expression and influences of IL-23/IL-17A in patients with stable COPD (n = 33) or acut...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792752/ https://www.ncbi.nlm.nih.gov/pubmed/35095906 http://dx.doi.org/10.3389/fimmu.2021.811803 |
_version_ | 1784640446984617984 |
---|---|
author | Ding, Fengming Han, Lei Fu, Qiang Fan, Xinxin Tang, Rong Lv, Chengjian Xue, Yishu Tian, Xue Zhang, Min |
author_facet | Ding, Fengming Han, Lei Fu, Qiang Fan, Xinxin Tang, Rong Lv, Chengjian Xue, Yishu Tian, Xue Zhang, Min |
author_sort | Ding, Fengming |
collection | PubMed |
description | Pseudomonas aeruginosa airway infection increases risks of exacerbations and mortality in chronic obstructive pulmonary disease (COPD). We aimed to elucidate the role of IL-17 in the pathogenesis. We examined the expression and influences of IL-23/IL-17A in patients with stable COPD (n = 33) or acute COPD exacerbations with P. aeruginosa infection (n = 34). A mouse model of COPD (C57BL/6) was used to investigate the role of IL-17A in host inflammatory responses against P. aeruginosa infection through the application of IL-17A–neutralizing antibody or recombinant IL-17A. We found that P. aeruginosa infection increased IL-23/17A signaling in lungs of both COPD patients and COPD mouse models. When COPD mouse models were treated with neutralizing antibody targeting IL-17A, P. aeruginosa induced a significantly less polymorphonuclear leukocyte infiltration and less bacterial burden in their lungs compared to those of untreated counterparts. The lung function was also improved by neutralizing antibody. Furthermore, IL-17A-signaling blockade significantly reduced the expression of pro-inflammatory cytokine IL-1β, IL-18, TNF-α, CXCL1, CXCL15 and MMP-9, and increased the expression of anti-inflammatory cytokine IL-10 and IL-1Ra. The application of mouse recombinant IL-17A exacerbated P. aeruginosa-mediated inflammatory responses and pulmonary dysfunction in COPD mouse models. A cytokine protein array revealed that the expression of retinol binding protein 4 (RBP4) was down-regulated by IL-17A, and exogenous RBP4-recombinant protein resulted in a decrease in the severity of P. aeruginosa-induced airway dysfunction. Concurrent application of IL-17A-neutralizing antibody and ciprofloxacin attenuated airway inflammation and ventilation after inoculation of P. aeruginosa in COPD mouse models. Our results revealed that IL-17 plays a detrimental role in the pathogenesis of P. aeruginosa airway infection during acute exacerbations of COPD. Targeting IL-17A is a potential therapeutic strategy in controlling the outcomes of P. aeruginosa infection in COPD patients. |
format | Online Article Text |
id | pubmed-8792752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87927522022-01-28 IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease Ding, Fengming Han, Lei Fu, Qiang Fan, Xinxin Tang, Rong Lv, Chengjian Xue, Yishu Tian, Xue Zhang, Min Front Immunol Immunology Pseudomonas aeruginosa airway infection increases risks of exacerbations and mortality in chronic obstructive pulmonary disease (COPD). We aimed to elucidate the role of IL-17 in the pathogenesis. We examined the expression and influences of IL-23/IL-17A in patients with stable COPD (n = 33) or acute COPD exacerbations with P. aeruginosa infection (n = 34). A mouse model of COPD (C57BL/6) was used to investigate the role of IL-17A in host inflammatory responses against P. aeruginosa infection through the application of IL-17A–neutralizing antibody or recombinant IL-17A. We found that P. aeruginosa infection increased IL-23/17A signaling in lungs of both COPD patients and COPD mouse models. When COPD mouse models were treated with neutralizing antibody targeting IL-17A, P. aeruginosa induced a significantly less polymorphonuclear leukocyte infiltration and less bacterial burden in their lungs compared to those of untreated counterparts. The lung function was also improved by neutralizing antibody. Furthermore, IL-17A-signaling blockade significantly reduced the expression of pro-inflammatory cytokine IL-1β, IL-18, TNF-α, CXCL1, CXCL15 and MMP-9, and increased the expression of anti-inflammatory cytokine IL-10 and IL-1Ra. The application of mouse recombinant IL-17A exacerbated P. aeruginosa-mediated inflammatory responses and pulmonary dysfunction in COPD mouse models. A cytokine protein array revealed that the expression of retinol binding protein 4 (RBP4) was down-regulated by IL-17A, and exogenous RBP4-recombinant protein resulted in a decrease in the severity of P. aeruginosa-induced airway dysfunction. Concurrent application of IL-17A-neutralizing antibody and ciprofloxacin attenuated airway inflammation and ventilation after inoculation of P. aeruginosa in COPD mouse models. Our results revealed that IL-17 plays a detrimental role in the pathogenesis of P. aeruginosa airway infection during acute exacerbations of COPD. Targeting IL-17A is a potential therapeutic strategy in controlling the outcomes of P. aeruginosa infection in COPD patients. Frontiers Media S.A. 2022-01-13 /pmc/articles/PMC8792752/ /pubmed/35095906 http://dx.doi.org/10.3389/fimmu.2021.811803 Text en Copyright © 2022 Ding, Han, Fu, Fan, Tang, Lv, Xue, Tian and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Ding, Fengming Han, Lei Fu, Qiang Fan, Xinxin Tang, Rong Lv, Chengjian Xue, Yishu Tian, Xue Zhang, Min IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title | IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_full | IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_fullStr | IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_full_unstemmed | IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_short | IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_sort | il-17 aggravates pseudomonas aeruginosa airway infection in acute exacerbations of chronic obstructive pulmonary disease |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792752/ https://www.ncbi.nlm.nih.gov/pubmed/35095906 http://dx.doi.org/10.3389/fimmu.2021.811803 |
work_keys_str_mv | AT dingfengming il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease AT hanlei il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease AT fuqiang il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease AT fanxinxin il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease AT tangrong il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease AT lvchengjian il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease AT xueyishu il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease AT tianxue il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease AT zhangmin il17aggravatespseudomonasaeruginosaairwayinfectioninacuteexacerbationsofchronicobstructivepulmonarydisease |